ENGAGING THE VALUE OF LIVING LABS TO INNOVATE CARE AND REGULATORY ENVIRONMENTS
EVOLVE2CARE focuses on HealthTech experimentation practice to standardize and enhance the collaboration between Living Labs and innovators in the context of the Transitional Care sector. The project will provide innovators with access to services for testing and validating research and products.
Grant agreement: Nº 101158152
Duration
10.2024 – 09.2026
Programme badge
Horizon Europe
Project Budget
€987,230
The Challenge: HealthTech innovators often face fragmented experimentation, regulatory and validation processes, making it difficult to test, commercialise and scale solutions that improve transitional care across healthcare systems.
Our Objective: To create a market-oriented experimentation framework that connects innovators, Living Labs and key healthcare stakeholders, enabling faster testing, validation and commercialisation of HealthTech solutions.
Innovation & Impact: EVOLVE2CARE transforms Living Labs into connected innovation ecosystems through a European marketplace, accelerating the development and market uptake of HealthTech solutions while strengthening evidence-based collaboration across Europe.
Sploro plays a key role in the strategic execution of the project, leveraging its expertise in:
Open Call Management
Managing the full selection process for innovators and Living Labs, from drafting the open calls to application evaluation and participant onboarding.
Research, Quality & Data Management
Leading project research, quality assurance, risk management and FAIR data governance to ensure high-quality implementation and evidence-based outcomes.
Economic Impact
Helping HealthTech innovators reduce development costs and time to market through real-world testing and validation.
Ecosystem Impact
Building a pan-European Living Lab ecosystem that strengthens collaboration, knowledge sharing and innovation capacity.
Societal Impact
Improving transitional care by placing patients, caregivers and healthcare professionals at the centre of innovation.
Market Impact
Accelerating the commercialisation of HealthTech solutions by connecting innovators with Living Labs and key healthcare stakeholders.
Technological Impact
Advancing market-ready HealthTech solutions through real-world experimentation and interoperability testing.
Regulatory Impact
Generating evidence to support more innovation-friendly regulatory frameworks for HealthTech across Europe.
The EVOLVE2CARE consortium brings together 5 partners from 5 European countries
Aristotle University of Thessaloniki (AUTH)
European Network of Living Labs (ENoLL)
Anthology Ventures (AV)
VILABS
Sploro
Explore and download EVOLVE2CARE’s public deliverables on Zenodo
